This bill amends existing New Jersey law regarding the administration of epinephrine in schools during emergencies related to anaphylaxis. It expands the mechanisms permitted for administering epinephrine from solely using a pre-filled auto-injector to allowing any FDA approved mechanism. The bill outlines the responsibilities of school boards and administrators in developing policies for epinephrine administration, which include obtaining written authorization from parents or guardians, ensuring proper training for school staff, and maintaining a supply of FDA approved epinephrine administration devices.

Additionally, the bill stipulates that school nurses or trained designees can administer epinephrine to any pupil suspected of having an anaphylactic reaction, even if there is no known history of anaphylaxis or if parental requirements have not been met. It also emphasizes the need for clear communication regarding liability and indemnification for the school district and its employees in the event of injury resulting from the administration of epinephrine. The changes aim to enhance the safety and responsiveness of schools in managing allergic emergencies.

Statutes affected:
Introduced: 18A:40-12.5, 18A:40-12.6